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AbstrAct
background It has been established that mass media 
campaigns can increase smoking cessation rates, but 
there is little direct evidence estimating associations 
between government expenditure on tobacco control 
mass media campaigns and smoking cessation. This 
study assessed the association over 8 years between 
mass media expenditure in England and quit attempts, 
smoking cessation and smoking prevalence.
Methods Autoregressive integrated moving average 
modelling with exogenous variables (ARIMAX) was 
applied to monthly estimates from the Smoking Toolkit 
Study between June 2008 and February 2016. We 
assessed the association between the trends in mass 
media expenditure and (1) quit attempts in the last two 
months, (2) quit success among those who attempted to 
quit and (3) smoking prevalence. Analyses were adjusted 
for trends in weekly spending on tobacco by smokers, 
tobacco control policies and the use of established aids 
to cessation.
results Monthly spending on mass media campaigns 
ranged from nothing to £2.4 million, with a mean of 
£465 054. An increase in mass media expenditure of 
10% of the monthly average was associated with a 
0.51% increase (of the average) in success rates of 
quit attempts (95% CI 0.10% to 0.91%, p=0.014). 
No clear association was detected between changes in 
mass media expenditure and changes in quit attempt 
prevalence (β=–0.03, 95% CI –2.05% to 2.00%, 
p=0.979) or smoking prevalence (β=–0.03, 95% CI 
–0.09% to 0.03%, p=0.299).
conclusion Between 2008 and 2016, higher monthly 
expenditure on tobacco control mass media campaigns 
in England was associated with higher quit success 
rates.
IntroductIon
The WHO’s Framework Convention on Tobacco 
Control mandates countries to promote ‘public 
awareness about the health risks of tobacco 
consumption and exposure to tobacco smoke, and 
about the benefits of the cessation of tobacco use 
and tobacco-free lifestyles’.1 Tobacco control mass 
media campaigns aim to raise the salience of the 
harmful effects of smoking, promote quitting, and 
often provide information on how to obtain help to 
quit.2 Tobacco control mass media campaigns are 
considered to be an important part of a comprehen-
sive tobacco control strategy3 due to their poten-
tial impact4–6 by decreasing cigarette consump-
tion7 8 and smoking prevalence7–9 and increasing 
quitting-related behaviours.10–13
In spite of the available evidence, there remains 
the crucial question as to what effect can be achieved 
for a given level of expenditure on tobacco control 
mass media campaigns by national governments.14 
A review of 10 studies reported that mass media 
campaigns are cost-effective in terms of life years 
or quality-adjusted life-years gained.15 However, 
evidence is largely limited to studies of specific 
campaigns and expenditure over a relatively short 
period of time.16–19 Evaluations of expenditure over 
a more extended period have been conducted in 
the USA, where they found a positive association 
with calls to quitlines20 and a negative association 
with cigarette sales.21 Moreover, a freeze on mass 
media expenditure in the UK was associated with 
a decrease in the use of smoking cessation litera-
ture, quitline calls and hits on the national smoking 
cessation website.10 However, there is little evidence 
linking expenditure and actual quitting. Evaluations 
of specific campaigns such as No Smoking Day22 or 
Stoptober17 may provide different results from an 
analysis of mass media spending extending over a 
period of a year or more.
The US Centers for Disease Control (CDC) Best 
Practices for Comprehensive Tobacco Control 
Programs recommend an investment in tobacco 
control mass media campaigns of $0.65 to $1.95 
per person per year.23 England has for the past 15 
years had a strong tobacco control climate24 and 
has run mass media campaigns for most of that 
time, although not at the level recommended by 
the CDC. In recent years, spending on campaigns 
in England has varied markedly, including a mora-
torium on spending on major ‘above the line’ 
campaigns (that is, campaigns using traditional 
forms of media) when the Conservative-Liberal 
Democrat coalition came to power in 2010–2011.10 
This ‘natural experiment’ provides a unique oppor-
tunity to study the impact of mass media spending 
across a wide range of values over a period of years.
This study aimed to assess the associations 
between changes in mass media tobacco control 
expenditure in England and changes in popula-
tion-level quit attempt rates, smoking cessation 
rates and smoking prevalence. These outcome 
measures address the hypotheses that mass media 
campaigns may encourage smokers to attempt quit-
ting, could lead to more successful smoking cessa-
tion and lower smoking prevalence. We included 
data on mass media expenditure before and after the 
2010–2011 moratorium, which provided us with a 
large variation in expenditure data. With the use of 
the Smoking Toolkit Study, involving monthly cross 
sectional surveys of representative samples of the 
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adult population of England, we were able to compare expendi-
ture trends with trends in smoking behaviour while adjusting for 
important developments in tobacco spending, use of cessation 
aids and tobacco control over time. This provides information 
that complements previous evaluations of tobacco control mass 
media campaigns.15
Methods
data and study population
Data were obtained from 165 420 individuals between June 2008 
and February 2016 taking part in Smoking Toolkit Study (STS), 
a population survey of adults aged 16+ (www. smokinginen-
gland. info). In the STS, each month a new sample of approxi-
mately 1800 adults aged ≥16 years is selected using a form of 
random location sampling. Individuals complete a face-to-face 
computer-assisted household interview survey with a trained 
interviewer. The STS samples have been shown to be nation-
ally representative in their sociodemographic composition and 
proportion of smokers in the population 16+. Ethical approval 
was granted by the University College London ethics committee. 
Full details of the STS methods have been described elsewhere.25
Measures
Smoking behaviour
Smoking was measured with the question: ‘Which of the 
following best applies to you?’, with response options: (1) ‘I 
smoke cigarettes (including hand-rolled) every day’, (2) ‘I smoke 
cigarettes (including hand rolled), but not every day’, (3) ‘I do 
not smoke cigarettes at all, but I do smoke tobacco of some other 
kind’, (4) ‘I have stopped smoking completely in the last year’, 
(5) ‘I have stopped smoking completely more than a year ago’, 
(6) ‘I have never been a smoker (ie, I have never smoked for a 
year or more)’. Last-year smokers were defined as individuals 
selecting answers 1 through 4. Individuals selecting options 1 
through 3 were considered to be current smokers. Smoking 
prevalence was measured as the proportion of current smokers 
in the total population.
Quit attempts in the last 2 months were measured among last-
year smokers who answered: ‘How many serious attempts to 
stop smoking have you made in the last 12 months?’, and if one 
or more attempts were reported: ‘How long ago did your most 
recent serious quit attempt start?’. We distinguished those who 
attempted to quit up to 2 months ago versus those who made no 
quit attempt or attempted to quit more than 2 months before 
the interview but were not successful. Last-year smokers who 
had successfully quit smoking more than 2 months before the 
interview were excluded for the analysis on quit success.
Successful quit attempts in last 2 months were defined as 
last-year smokers who attempted to quit in the last 2 months 
(defined as described above) who were still not smoking at the 
time of the interview. This only represents short-term success, 
but to go back further would have increased the risk of bias from 
forgotten quit attempts,26 and long-term quit success in large 
samples can be reliably estimated from short-term success. The 
relapse rate between 1 month and 1 year is approximately 70%, 
and between 1 year and 10 years is approximately 30%.27
Mass media expenditure
Data on tobacco control campaign expenditure in England 
were provided by Public Health England. Total spending on 
campaigns was provided for each period in which the campaign 
ran, which in many cases included multiple months. Spending (in 
million £) on ‘Smokefree’ campaigns, Stoptober campaigns and 
Health Harms campaigns were summed and monthly expendi-
ture was extracted. Monthly totals included expenditure on TV, 
radio, print, cinema and online advertisements. In the months 
in which there was no campaign running and thus no campaign 
expenditure reported, Public Health England (PHE) confirmed 
that campaign expenditure could be regarded as effectively zero, 
and thus expenditure values were set to a nominal value of 0.01 
(£10 000; zero values cannot be modelled). Expenditure figures 
diverge from those reported earlier (eg, in Action on Smoking 
and Health (ASH) publications28), as ‘lead generation’ expendi-
ture was included in the ASH figures but not in the present study. 
Lead generation involved using databases to attempt to route 
individual smokers to stop smoking services.
Potential confounding variables
We included a variable reflecting the course of tobacco control 
policies in England. The value of the tobacco control variable 
increased by one unit with the introduction of each new policy 
in the study period (June 2008–February 2016) and was assigned 
to the month of when the policy was implemented. Over time, 
the variable values ranged from 1 to 7, with one point added 
when each of the following six tobacco control policies were 
implemented: (1) October 2009: pictorial warnings on cigarette 
packs, (2) October 2010: pictorial warnings on all tobacco prod-
ucts, (3) October 2011: ban on sale of tobacco from vending 
machines, (4) October 2013: ban advertising at the point of sale, 
(5) April 2013: ban on displaying cigarette packs in large shops, 
(6) April 2015: ban on displaying cigarette packs in small shops. 
As this variable was ‘differenced’ in the analysis (see Statis-
tical Analysis), it amounted to an impulse of 1 in a month in 
which a new policy was introduced versus 0 in all other months.
Current smokers estimated their weekly spending on tobacco 
(in £). Weekly spending was adjusted for inflation using UK 
Consumer Price Index (CPI) information from the Office of 
National Statistics: adjusted spending = (spending/CPI)×100. 
Weekly spending was missing for survey waves between July 
2009 and July 2010, for which a linear trend in mean spending 
is imputed.
The use of any cessation aids in a quit attempt including 
prescription medication (varenicline or bupropion), prescrip-
tion nicotine replacement therapy (NRT) or electronic cigarettes 
(e-cigarettes) were measured among last-year smokers attempting 
to quit. The use of e-cigarettes, prescribed NRT, varenicline and 
bupropion have previously been shown to support successful 
quitting in this population.29 30 Use of NRT bought over the 
counter in quit attempts has not been found to increase quit rates 
in this population29 and was therefore not included.
statistical analysis
The analysis plan was registered on the Open Science Framework 
prior to data analysis (https:// osf. io/ gudrv/). An amendment was 
made to the analysis plan subsequently. The decision was made 
not to conduct the subgroup analyses due to the complexity of 
the overall results in terms of the number of lags and presence 
of autocorrelation.
Data were aggregated monthly as weighted means or propor-
tions and analysed between April and July 2016 in R V.3.3.2. 
Means and proportions were weighted for gender, working 
status, prevalence of children in the household, age, social grade 
and region, as described in Fidler et al.25
We applied Autoregressive Integrated Moving 
Average (ARIMA) with Exogenous Input (ARIMAX) modelling, 
which is comparable to methods used in other tobacco control 
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evaluation studies.9 12 ARIMAX is similar to ARIMA analysis, 
in that it uses forecasts based on prior values in the time series 
(autoregressive terms (AR)) and errors made by previous predic-
tions (moving average terms (MA)). Additionally, ARIMAX can 
assess associations between multiple time series, allowing control 
for other processes taking place over time. We followed a stan-
dard ARIMAX modelling approach which is given in more detail 
in the preregistered analysis plan.31
Time series analysis requires stationary data. To achieve this, 
the series are first log transformed to stabilise the variance and, if 
required, are differenced and seasonally differenced. The differ-
enced value of Y at month t would be Yt–Yt-1 and the season-
ally differenced value would be Yt–Yt-12. Differencing attempts 
to remove underlying linear and cyclical trends. The autocor-
relation and partial autocorrelation functions were examined to 
determine the seasonal and non-seasonal MA and AR. To iden-
tify the most appropriate transfer function for the continuous 
explanatory variables, the sample cross-correlation function was 
checked for each ARIMAX model. ARIMAX models with several 
combinations of values for p (the number of autoregressive 
terms) and q (the number of lagged forecast errors), and several 
lags were run, and the models with the best fit were presented. 
Additionally, a model without lag for mass media expenditure 
was estimated. A detailed explanation of the model selection is 
available in the online supplementary material. Coefficients can 
be interpreted as estimates of the percentage change in the mean 
outcome of interest across the study period for every percentage 
increase in mass media expenditure above the monthly mean 
across the study period. In the tables, the coefficients were 
multiplied by 10 to represent the change with a 10% increase in 
expenditure. STROBE guidelines were followed.32
In sensitivity analyses, we tested models without lags for all 
covariates and models with additional AR and MA terms. In all 
sensitivity analyses, the results for mass media expenditure were 
compared with the results of the main analysis.
results
Descriptive statistics are presented in table 1, figure 1 and 
figure 2. Over the period June 2008 to February 2016, Public 
Health England spent £43.2 million on tobacco control mass 
media campaigns. As depicted in figure 1, expenditure varied 
over the years, and was generally high in 2008 and 2009, after 
which it dropped to zero during a moratorium on spending. 
Expenditure resumed in 2012 to 2015. Table 1 and figure 1 
show that the weighted smoking prevalence over the total 
study period was 20.6% (95% CI 20.4% to 20.8%) and that it 
decreased over time. The 2-month quit attempt rate (percentage 
of smokers having made a quit attempts in the past 2 months) 
over the total period was 10.3% (95% CI 9.9% to 10.6%) and 
somewhat increased over time, while quit success among those 
who attempted to quit did not show a clear linear trend and fluc-
tuated around 20% (table 1 and figure 1). The use of cessation 
aids rapidly increased (table 1 and figure 2).
Table 2 shows the percentage change in quit attempts for a 10% 
increase in mass media expenditure above the monthly average, 
as estimated in the ARIMAX models. Mass media expenditure 
was not significantly associated with concurrent change in quit 
attempts rates (per cent change −0.04, 95% CI −0.63 to 0.54, 
p=0.883), nor was it significantly associated with quit attempts 
2 months later (per cent change −0.05, 95% CI −0.67 to 0.56, 
p=0.861). Results were similar in the unadjusted and adjusted 
models. Table 2 also shows that the quit attempt rate was not 
associated with smokers’ weekly spend on tobacco or with 
tobacco control policies.
Table 3 shows ARIMAX results for quit success. With every 
10% increase in mass media expenditure above the monthly 
average, successful smoking cessation among quitters immedi-
ately increased by 0.55% (95% CI 0.15 to 0.96, p=0.007) in the 
unadjusted model and by 0.51% (95%CI 0.10 to 0.91, p=0.014) 
in the adjusted model. A lag of 1 month for mass media expen-
diture, although with a lower model fit, led to a comparable 
increase in quit success (per cent change 0.49, 95% CI 0.10 to 
0.87, p=0.013). Covariates did not show significant associations 
with quit success.
Table 4 shows ARIMAX results for smoking prevalence. A 
significant decrease in smoking prevalence in response to mass 
media expenditure was not observed and results were the same 
for models without a lag and with a lag of 2 months (percent 
change −0.03, 95% CI −0.09 to 0.03, p=0.299). Covariates 
did not show significant associations with smoking prevalence, 
although the use of cessation aids tended to be associated with 
lower smoking rates (percent change −0.18, 95% CI −0.39 to 
0.03, p=0.097).
dIscussIon
Key findings
Government spending on mass media campaigns ranged 
from nothing to £2 400 000 per month. No clear association 
was detected between changes in mass media expenditure 
and changes in concurrent quit attempts, quit attempts in the 
following 2 months or smoking prevalence. However, every 
10% increase in mass media expenditure above the monthly 
average was associated with a 0.51% increase from the average 
in short-term success of quit attempts.
table 1 Description of national tobacco control mass media expenditure and weighted individual level variables by survey period, in % with 
95% CI, unless otherwise specified
total June 2008–
February 2016
June 2008–december 
2010
January 2011–december 
2013
January 2014–February 
2016
Mass media expenditure (total in million £) 43.2 15.2 14.0 14.1
In the total population, N 1 65 420 56 355 65 443 43 622
  Current smoking 20.6 (20.4–20.8) 22.1 (21.8–22.5) 20.4 (20.1–20.7) 19.0 (18.6–19.4)
In smokers, N 37 013 13 120 14 331 8487
  Quit attempts 10.3 (9.9–10.6) 10.0 (9.5–10.6) 10.4 (9.9–11.0) 10.4 (9.7–11.1)
  2-month quit success in those who attempted to quit 19.9 (18.5–21.3) 20.2 (18.0–22.7) 18.8 (16.7–21.1) 21.0 (18.2–24.1)
  Cessation aids use 28.2 (27.4–29.1) 18.7 (17.6–19.9) 28.8 (27.5–30.2) 42.6 (40.6–44.5)
  Weekly spend tobacco (mean in £, 95% CI) 20.9 (20.7 to 21.1) 19.9 (19.5 to 20.2) 21.1 (20.8 to 21.4) 21.6 (21.2 to 22.0)
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study limitations
This study had a number of limitations. First, the association 
observed between expenditure and quit success may not be causal, 
but due to unmeasured confounding. We attempted to control 
for major factors that could affect success of quit attempts at a 
population level, including the rise in popularity of e-cigarettes.33 
However, it remains possible that our measures were not suffi-
ciently precise or that there was residual confounding. For 
example, campaigns may influence social norms to be less 
accepting of smoking,34 which increases support for more tobacco 
control investment and may in turn increase mass media expendi-
ture. However, Granger causality tests were performed as a part 
Figure 1 Weighted monthly trends of (A) quit attempts in the last 2 months, (B) quit success in those who attempted in the last 2 months and (C) 
smoking prevalence in the general population and the expenditure on mass media tobacco control campaigns in pound per month.
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of the ARIMAX analyses and found weak exogeneity between 
mass media expenditure and all three smoking outcomes.
Second, we relied on self-reports of smoking and quitting. 
These may be subject to error and bias. For example, failed quit 
attempts tend to be forgotten relatively quickly, and this could 
weaken our ability to detect an effect on quit attempts. On the 
other hand, these measures have shown reliable associations 
with other factors that influence quitting, such as use of e-ciga-
rettes33 and cigarette warning labels.35
Third, while the sample was intended to be representative 
and had characteristics that were similar to other large popu-
lation samples in England,25 it is likely that there is bias in the 
type of people who respond to these kinds of surveys. This is an 
important area for study as it appears that there is a reduced will-
ingness on the part of the general public to take part in surveys.36 
The results of the current study may be biased if participants are 
more engaged in societal issues and perhaps more responsive to 
mass media campaigns than non-participants.
Figure 2 Weighted monthly trends in the use of e-cigarettes, prescription nicotine replacement therapy and prescription medication by smokers 
who attempted to quit in the last year (in %), weekly spend on tobacco by smokers (in £) and tobacco control policies.
table 2 Estimated percentage change in quit attempts (the proportion of smokers who attempted to quit in the past 2 months) per 10% change in 
mass media expenditure from ARIMAX models
Quit attempts unadjusted Adjusted for covariates in table
Percentage change per 10% change in the exposure 
(95% cI), p Value
Percentage change per 10% change in the exposure 
(95% cI), p Value
Model 1
  Mass media expenditure (lag 0) −0.04 (-0.63 to 0.54), 0.883 −0.03 (-0.62 to 0.56), 0.931
  Weekly spend tobacco (lag 4) −0.51 (-2.89 to 1.87), 0.677
  Tobacco control policies 0.06 (-0.49;0.62), 0.830
  Best fitting model ARIMAX (0, 1, 1) (0, 0, 0) ARIMAX (0, 1, 1) (0, 0, 0)
  Non-seasonal (p)—AR NA NA
  —MA <0.001 <0.001
  Seasonal (p)—AR NA NA
  —MA NA NA
  R2 0.010 0.012
Model 2
  Mass media expenditure (lag 2) −0.05 (-0.67 to 0.56), 0.861 −0.03 (-2.05 to 2.00), 0.979
  Weekly spend tobacco (lag 4) −0.51 (-2.94 to 1.93), 0.684
  Tobacco control policies −0.06 (-0.50 to 0.62), 0.831
  Best fitting model ARIMAX (0, 1, 1) (0, 0, 0) ARIMAX (0, 1, 1) (0, 0, 0)
  Non-seasonal (p)—AR NA NA
  —MA <0.001 <0.001
  Seasonal (p)—AR NA NA
  —MA NA NA
  R2 0.010 0.012
The assumption of normally distributed errors was met. When the lag for weekly tobacco spend was set to zero, results for mass media were similar in model 1 (β=−0.04 
(–0.63 to 0.54) , p=0.882) or in model 2 (β=−0.05 (-0.66; to 0.56), p=0.864). Addition of MA or AR terms did not improve the models. 
AR, autoregressive terms; ARIMAX, Autoregressive integrated moving average modelling with exogenous variables;MA, moving average terms.
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Fourth, the findings represent trends in England over a partic-
ular time period with particular kinds of mass media campaigns, 
and an optimal level of expenditure could not be identified. It is 
possible that different results would be obtained in other circum-
stances with different campaign strategies.7 11 37 This means that 
the effectiveness of England’s future mass media expenditure 
and expenditure by foreign governments is not guaranteed by 
our results. However, England’s mass media campaign strategy 
is broadly similar—including use of similar material—to other 
countries, such as Australia. The fact that the association with 
quit success was found over a relatively long period of study 
with a variety of different types of campaigns, probably gives 
a broad indication of what can be achieved by a well-informed 
campaign strategy. In 2004–2010, 89% of tobacco control mass 
table 3 Estimated percentage change in quit success (the proportion successful quitters among those who made an attempt in the past 2 months) 
per 10% change in mass media expenditure from ARIMAX models
Quit success unadjusted Adjusted for covariates in table
Percentage change per 10% change in the exposure 
(95% cI), p Value
Percentage change per 10% change in the exposure 
(95% cI), p Value
Smoking cessation
  Mass media expenditure (lag 0) 0.55 (0.15 to 0.96), 0.007 0.51 (0.10 to 0.91), 0.014
  Weekly spend tobacco (lag 0) −16.83 (-37.41 to 3.75), 0.109
  Cessation aid use (lag 4) 2.11 (-1.51 to 5.73), 0.254
  Tobacco control policies −0.15 (-2.09 to 1.79), 0.878
  Best fitting model ARIMAX (0, 1, 1) (0, 0, 0) ARIMAX (0, 1, 1) (0, 0, 0)
  Non-seasonal (p)—AR NA <0.001
  —MA <0.001 NA
  Seasonal (p)—AR NA NA
  —MA NA NA
  R2 0.075 0.112
Additional MA (0, 1, 2) or AR (1, 1, 1) terms were not significant.   The assumption of normally distributed errors was met. When all lags were set to zero in the adjusted model, 
similar results were found for mass media (β=0.50 (0.10 to 0.90), p=0.015). A lag of 1 month for mass media expenditure, although with a considerably worse fit, led to a 
comparable increase in quit success (β=0.49 (0.10 to 0.87), p=0.013). 
AR, autoregressive terms; ARIMAX, Autoregressive integrated moving average modelling with exogenous variables;MA, moving average terms.
table 4 Estimated percentage change in smoking prevalence (the proportion of smoking in the general population) per 10% change in the 
exposure from ARIMAX models
smoking prevalence unadjusted Adjusted for covariates in table
Percentage change per 10% change in the exposure 
(95% cI), p Value
Percentage change per 10% change in the exposure 
(95% cI), p Value
Model 1
  Mass media expenditure (lag 0) −0.03 (-0.09 to0.03), 0.275 −0.03 (-0.09 to 0.02), 0.258
  Weekly spend tobacco (lag 1) 0.08 (-0.09 to 0.25), 0.371
  Cessation aid use (lag 1) −0.18 (-0.38 to 0.03), 0.096
  Tobacco control policies −0.54 (-1.44 to 0.36), 0.238
  Best fitting model ARIMAX (0, 1, 1) (0, 0, 0) ARIMAX (0, 1, 1) (0, 0, 0)
  Non-seasonal (p)—AR NA NA
  —MA <0.001 <0.001
  Seasonal (p)— AR NA NA
  —MA NA NA
  R2 0.465 0.527
Model 2
  Mass media expenditure (lag 3) −0.03 (-0.09 to 0.03), 0.269 −0.03 (-0.09 to 0.03), 0.299
  Weekly spend tobacco (lag 1) −0.08 (-0.10 to 0.25), 0.379
  Cessation aid use (lag 1) −0.18 (-0.39 to 0.03), 0.097
  Tobacco control policies −0.54 (-1.44 to 0.35), 0.235
  Best fitting model ARIMAX (0, 1, 1) (0, 0, 0) ARIMAX (0, 1, 1) (0, 0, 0)
  Non-seasonal (p)—AR NA NA
  —MA <0.001 <0.001
  Seasonal (p)—AR NA NA
  —MA NA NA
  R2 0.465 0.527
The assumption of normally distributed errors was met. When lags of tobacco spending and cessation use were set to zero very similar results were found for mass media in 
model 1 (β=−0.03 (-0.09 to 0.02), p=0.238) and in model 2 (β=−0.03 (-0.10 to 0.03), p=0.278). Additional MA (0, 1, 2) or AR (1, 1, 1) terms were not significant.
AR, autoregressive terms; ARIMAX, Autoregressive integrated moving average modelling with exogenous variables;MA, moving average terms.
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media campaigns was for smoking cessation, among which half 
contained how-to-quit messages.2
Interpretation
Mass media expenditure in England over the period of the study 
was associated with more successful quitting among those who 
attempted to stop. This is in line with findings from a controlled 
trial in four regions in central and northern England, which 
found that an antismoking TV campaign that provided tips on 
how to prevent relapse was effective in helping prevent relapse.13 
Relapse prevention tips were also found to be helpful in a study 
among ex-smokers in the USA.38 Another US study found that 
tips on how to quit from former smokers increased quit success 
among smokers making a quit attempt.39 Quit success may be 
increased due to mass media campaigns sustaining motivation 
to persist with the quit attempt by maintaining the salience of 
quitting or making quitting appear more normative.4 34 More-
over, smokers may more often seek professional help as a result 
of how-to-quit messages, such as behavioural or cognitive 
therapy, support groups, quitlines or other forms of professional 
support.12 This was demonstrated by Langley et al,10 showing 
that stopping mass media spending significantly reduced the 
number of literature requests, quitline calls and website hits.
If the relationship between mass media expenditure and 
quit success found in this study is causal, we can estimate that 
every 10% increase in expenditure would result in a 0.51% 
increase in short-term success rates, other things being equal. 
The mean quit success rate over the studied period would 
have been 19.98% instead of 19.87% if mass media expen-
diture was 10% higher. Over the study period, the monthly 
average expenditure on mass media campaigns was £465 054, 
or £5 580 644 per year, and according to the STS data 35.3% 
of smokers made a quit attempt in the last year. Our data 
showed that 19.9% of these quit attempts were successful 
after 2 months, and according to previous studies 55% of 
these quit attempts remained successful after 6 months27. With 
8 million smokers in England, this amounts to 308 638 people 
(8 000 000×0.353×0.199×0.55). Thus, our findings suggest 
that if spending on mass media campaigns were increased 
by £1 million per year, there would have been an additional 
5129 short-term ex-smokers. Applying an adjustment for 
subsequent relapse this would translate to 2500 people who 
stopped smoking permanently.27 Assuming that most smokers 
who would have stopped were in middle age, this amounts to 
2903 additional life years gained at a cost of £344 (95% CI 
193 to 1757) per life year using a standard annual discount rate 
of 3.5%.27 This incremental cost-effectiveness ratio of £344 
is comparable with findings from previous cost-effectiveness 
studies on mass media campaigns.16 17 40–42
The failure to find a clear association of expenditure with quit 
attempts seems to conflict with previous studies.4 In fact, we 
cannot conclude that there was no effect of mass media campaign 
expenditure on quit attempts due to a wide confidence interval 
(ranging from −2.05 to 2.00), and previous studies have yielded 
mixed results.4 17 39 43–45 The circumstances in which mass media 
campaigns may increase quit attempts or not requires further 
study.
We did not find a significant association between mass media 
expenditure and smoking prevalence, although the association 
was in the expected direction. If the association we found with 
quit success is causal, the impact on smoking prevalence would 
only result in a 0.03% reduction in prevalence which we would 
be unlikely to detect with our sample size.
IMPlIcAtIons
Mass media expenditure is cost-effective at much lower costs 
than generally accepted thresholds for public health inter-
ventions: for example £20 000 as stated in the UK’s National 
Institute for Health and Care Excellence guidelines.46 Mass 
media expenditure in England has not increased since lifting 
the 2011 moratorium, and the English Department of Health 
announced a budget of £4 million for 2016/2017, compared 
with £5.3 million in 2015/2016, a cut of 25%.47 This could lead 
to 3251 fewer long-term ex-smokers. Increased expenditure on 
mass media campaigns, on the other hand, has the potential to 
reduce smoking, to gain life years and to have a positive return 
on investment.48
conclusIons
Between 2008 and 2016, higher expenditure on tobacco control 
mass media campaigns in England was associated with an 
increase in quit success rates. An association with quit attempts 
and smoking prevalence was not clearly established. For an addi-
tional million pounds spent per year over and above expenditure 
across the period, we estimate there could have been 2500 addi-
tional permanent ex-smokers.
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